HIV-1
FDA Authorizes Marketing of First Next-Generation Sequencing Test for Detecting HIV-1 Drug Resistance Mutations
U.S. Food & Drug Administration
PR-M11-19-NI-008Nov 08, 2019
HIV Prevention
FDA Approves Second Drug to Prevent HIV Infection as Part of Ongoing Efforts to End the HIV Epidemic
The US Food & Drug Administration
PR-M10-19-NI-008Oct 07, 2019
Study Results
Janssen Reports Positive Topline Results for ATLAS Phase III Study of a Novel, Long Acting Injectable Two-Drug Regimen for the Treatment of HIV-1
Janssen Pharmaceutical Companies
PR-M09-18-NI-045Sep 17, 2018
FDA Approval
Merck’s HIV-1 Drugs Delstrigo and Pifeltro Get FDA Approval
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M09-18-NI-003Sep 06, 2018
Commission Approval
Janssen Announces European Commission Approval of JULUCA®▼ (dolutegravir/rilpivirine), the First Two-Drug Regimen, Once-Daily, Single-Pill for the Treatment of HIV-1
Janssen Pharmaceutical Companies
PR-M05-18-NI-088May 23, 2018
Treatment
New Single-Pill HIV Treatment Approved in Europe
Guy Tiene
Nice Insight
PAO-M05-18-NI-015May 22, 2018
FDA Approval
U.S. Food and Drug Administration Approves Expanded Indication for Truvada®
Gilead Sciences
PR-M05-18-NI-073May 18, 2018